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Background. The study was carried out to assess the course and outcome of pregnancies in
women with the Ehlers–Danlos syndrome, with the aim of developing guidelines for
assessment of risk and counseling, and for providing optimum medical and obstetric care.
Methods. A retrospective study based on data collected from members of the Dutch
Association of Ehlers–Danlos patients. Pregnancies and neonatal outcomes of the affected
mothers were compared with those of the nonaffected mothers who delivered an infant with
Ehlers–Danlos syndrome.
Results. In a group of 46 women with Ehlers–Danlos syndrome, 128 pregnancies beyond 24
weeks gestation were evaluated and compared with 43 pregnancies of 33 nonaffected women.
The main maternal complications consisted of pelvic pain and instability (26% vs. 7%). One
bowel rupture was reported in a woman with Ehlers–Danlos syndrome type IV. Preterm
delivery occurred in 21% of the affected mothers compared with 40% of the nonaffected
women with an affected infant; the women with Ehlers–Danlos syndrome experienced
postpartum hemorrhage (19% vs. 7%) and complicated perineal wounds (8% vs. 0%) more
often than the unaffected women. The floppy infant syndrome was diagnosed in 13% of the
affected infants and did not occur in the nonaffected neonates.
Conclusion. Pregnancy is generally well-tolerated in women with Ehlers–Danlos syndrome,
with favorable maternal and neonatal outcomes. In Ehlers–Danlos syndrome type IV it may
be associated with severe maternal complications. Preconceptional counseling concerning
specific possible complications and a multidisciplinary approach are recommended.
Keywords: Ehlers–Danlos syndrome; maternal complications; neonatal outcome; obstetric
outcome; pregnancy
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The Ehlers–Danlos syndrome (EDS) constitutes a
heterogenous collection of rare disorders of the
connective tissue (1). The syndrome manifests itself
in a wide range of clinical signs and symptoms:
from mild skin laxity and joint hypermobility to
severe disabling luxations, and bleeding as a result
of a rupture of the greater vessels, or by a rupture
of the intestine (1–3). Ehlers–Danlos Syndrome
may be inherited, usually following an autosomal
dominant pattern, or may be caused by a new
mutation.
Nine different types of EDS have been iden-
tified, based on phenotypic manifestations, specific
biochemical and molecular abnormalities, and
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mode of inheritance (3). Most of the cases concern
types I, II and III (approximately 30% each); in
approximately 10% of the cases type lV is con-
cerned, and the remaining types are rare (1).
The prevalence of EDS used to be estimated at
1 :150.000, but recent reports suggest a prevalence
of 1 :5000 (1, 4). The prevalence may be even
higher because the disorder has become easier to
diagnose, and more subtypes are being identified
(1).
In conjunction with the syndrome a variety of
obstetric as well as medical complications are re-
ported and attributed to the fundamental collagen
defect. As a result of the rare occurrence of EDS
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it is difficult to estimate the true incidence of the
complications. Most articles on EDS and preg-
nancy present or review case reports, which are no-
torious for publication bias, as a dramatic compli-
cation or outcome often formed the reason for
publication (5–7). In a survey of clinical aspects
of EDS patients Ainsworth and Aulicino (8) report
the occurrence of preterm rupture of membranes
in 26–75% of cases, depending on the type of EDS,
and excessive bleeding antepartum was ‘often’ ob-
served. Postpartum complications consisting of se-
vere bleeding, lacerations of the birth canal, and
uterine prolapse were reported in 20–58% of cases.
In contrast with these reports, a survey of 138
pregnancies in 43 affected female members of the
American Ehlers–Danlos National Foundation re-
vealed no serious complications (9).
In this article a retrospective study is presented
based on data collected from members of the
Dutch Association of Ehlers–Danlos patients with
the aim of developing guidelines for the assessment
of risk and counseling of women with EDS who
are contemplating pregnancy, and for providing
optimum medical and obstetric care during preg-
nancy.
Subjects and methods
Study design
A letter was sent to approximately 170 members of
the Dutch Ehlers–Danlos Association requesting
them and their family to participate in the study.
Members are individuals who are registered with
the Dutch Ehlers–Danlos Association and include
(1): individuals with EDS (2); individuals belong-
ing to a family in which EDS occurs (3); and indi-
viduals with professional or emotional interests in
EDS. Response was obtained from 74 families, 16
of which refused to participate. Of the partici-
pating 58 families 66 of the affected women had
had one or more pregnancies, and 33 of the non-
affected women had delivered one or more affected
infants. All family members were approached
again by means of a letter or by telephone, or both,
and the objectives of the study and the information
required were explained in detail.
After informed consent had been obtained, gen-
eral data, clinical data with respect to EDS, and
data regarding the course and outcome of preg-
nancies and condition of the neonates were col-
lected by means of a detailed questionnaire from
the women with EDS who had been pregnant, and
from the nonaffected women with one or more
children with EDS. The diagnosis and the type of
EDS in the mothers and the neonates were con-
firmed in a center for clinical genetics in 82% of
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cases, according to the international nosology of
heritable disorders of the connective tissue (3); in
the remaining cases the diagnosis had been made
by a pediatrician, a dermatologist, or another
specialist involved. With regard to obstetric
characteristics, the nonaffected women were used
as controls for the affected women who constituted
the study group. Hospital records were called in
when available and needed. Data on pregnancies
that took place longer than 20years ago could not
be reliably assessed and were not included in the
analysis.
Statistical analysis
For statistical analysis the X2-test was used where
appropriate for proportional data. A p-value of ,
0.05 was taken to represent statistical significance.
Results
Patient data
Of the 168 EDS patients, 66 were women who had
been pregnant, with a total of 246 pregnancies, 194
of which were carried beyond 24weeks gestation.
Of these 194 pregnancies, 128 had occurred in 46
of the women in the past 20years; of all of these
pregnancies detailed clinical data on the course
and outcome of pregnancy, labor, delivery, and
neonatal outcome were available.
Of the nonaffected members of the Association,
33 women had had 107 pregnancies, 93 of which
were carried beyond 24weeks. Of the 93 pregnan-
cies, 43 had occurred in the past 20years and were
evaluable along with complete obstetric and neo-
natal data. These pregnancies resulted in the birth
of at least one affected infant; in 46% it concerned
a new mutation, and in 54% the father was
affected. The extent of preconceptional counseling
could not be reliably assessed in the majority of
cases in this study and was omitted from further
analysis.
General characteristics of all the pregnancies in
both groups are presented in Table I. The mean age
at first pregnancy was similar in the study and con-
trol group, and on average the affected women had
one pregnancy more than the nonaffected women.
In the control group of unaffected women the eval-
uable pregnancies comprised 46% of all gestations
carried beyond 24weeks vs. 66% in the study
group (p,0001).
Of the 66 women in the study group EDS type
l was found in 11%, type II in 27%, type III in
31%, and type IV in 11%. In 18% the type could
not be established with certainty, and in the re-
maining 2% one of the other types (VI, VII or
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Table I. General characteristics of the pregnancies of the Ehlers–Danlos patients and the unaffected women. Values are presented as n, mean, and (range)
Affected Unaffected
Number of women 66 33
Mean age at first pregnancy (year) 23 (19–32) 24 (20–29)
Mean age at last pregnancy (year) 29 (21–37) 28 (25–38)
Pregnancies per woman 4 (1–9) 3 (1–4)
Total number of pregnancies 246 107
Total number of pregnancies . 24 week 194 93
Early abortions (, 16 week) 41 14
Late abortions (16–24 week) 11 0
VIII) was present. One woman had the Marfan
syndrome combined with type IV EDS.
Course and outcome of pregnancy
Rates of early abortion were not different between
pregnancies in the EDS patients (17%) and the
nonaffected women (13%). Late abortions oc-
curred in 4.5% of pregnancies in the women with
EDS, and the numbers are too small to distinguish
between types.
The course and outcome of pregnancies carried
beyond 24weeks in 46 of the affected and 33 of the
unaffected women are presented in Table II. The
incidences of blood loss during pregnancy and of
pre-eclampsia were not different between the
groups. Of the seven cases of proteı¨nuric pre-ec-
lampsia in the patients with EDS, four occurred in
type lV. The preterm delivery rate, defined as deliv-
ery after 24 and before 37 completed weeks was
22% in the affected women compared with almost
twice that in the group of nonaffected women
(40%); a significant difference. However, in the
affected women with a nonaffected fetus the pre-
term delivery rate was 12.5%. In both groups the
preterm delivery was preceded in the majority of
cases by preterm rupture of membranes (PROM).
In the nonaffected women with an affected fetus
PROM occurred more than twice as often (50%)
than in the affected women (20%) with or without
an affected fetus (p,0001). In pregnancies of the
affected women with an affected fetus proven by
later examination of the infant, PROM occurred in
35%. Four women with EDS had twin pregnancies,
three of which ended in late abortion and one in
preterm delivery at 29weeks. No information was
available on whether or not the infants were
affected.
Rates of protracted labor, defined by the necess-
ity to augment labor with oxytocin, were similar in
both the groups. An abnormal fetal presentation
at delivery was observed in 12% of the pregnancies
in the affected women, compared with 2% in the
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controls; the difference is not statistically signifi-
cant. A breech delivery was reported in 10 cases
(8%), compared with one case in the control
group; in five of the 10 cases the newborn was
affected. In three cases a brow presentation oc-
curred, and twice a face presentation was found;
these infants were all affected. The incidence of ab-
normal presentations was highest in the women
with EDS type III (19%), and in the other types it
occurred only incidentally. In 8% of the affected
women who delivered vaginally complicated
births, lesions of the birth canal were reported: five
deliveries were associated with third-degree peri-
neal lacerations, and in five cases healing of an epi-
siotomy wound appeared to have been compli-
cated. These complications were not reported in
the control group.
Seven of the affected women delivered by
cesarean section. The indications were cervical
dystocia in four cases and fetal distress in three
cases. In three of the cases the diagnosis of EDS
was known and measures were taken to prevent
surgical complications, such as gentle tissue han-
dling, meticulous hemostasis, and attention to
skin adaptation. In these cases no postoperative
complications occurred; in the other four cases
wound dehiscence and wound infection occurred
in one patient. No cesarean sections were re-
ported in the control group. One patient (EDS
type IV) presented with complications of epidural
analgesia, consisting of leakage of spinal fluid,
and severe headache.
Hemorrhage postpartum, defined as blood loss
of more than 1000mL or any blood loss necessitat-
ing blood transfusion, was found almost three
times more often in the affected women (19%) than
in the controls (7%); the difference at the 5% level
is just significant. When both the newborn and the
mother were affected, postpartum hemorrhage oc-
curred in 33% of cases. The highest incidence was
observed in 16 deliveries by the women with an
uncertain type of EDS (43%), followed by an inci-
dence of 33% in the women with type I.
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Table II. Course and outcome of the evaluable pregnancies . 24 weeks of the Ehlers–Danlos patients and the unaffected women. Values are numbers
Affected Unaffected
Number of women 46 33
Evaluable pregnancies . 24 week 128 43
Number of pregnancies with EDS infant 48 43
Number of pregnancies with
unaffected infant 55 64
unknown if infant is affected 25
Obstetric complications
Pre-eclampsia 7 1
Blood loss during pregnancy 12 2
PROM* 25 21
Fetal death 2 0
Delivery
Protracted labor 12 6
Spontaneous vaginal 112 40
Forceps 5 1
Vacuum 4 2
Cesarean section 7 0
Abnormal presentation 15 1
Births
Preterm 28† 17‡
Term 101 26†‡
Postpartum complications
Hemorrhage 24 3
Manual removal of placenta 3 2
Third-degree perineal tear 5 0
Complicated healing of episiotomy 5 0
Maternal complications
Maternal death 0 0
Ruptured bowel 1 0
Incarceration of retroverted uterus 1 0
Deep venous thrombosis 2 0
Pelvic pain/instability 34 3
*Preterm rupture of membranes.
†One twin pregnancy: one infant affected.
‡Only affected infants.
EDS, Ehlers-Danlos syndrome; PROM, preterm rupture of membranes.
Effects of pregnancy on the Ehlers–Danlos
syndrome
No maternal deaths were reported. One woman
with EDS type IV suffered a spontaneous rupture
of the colon on the first day after spontaneous va-
ginal delivery, following an uncomplicated preg-
nancy. She recovered after a complicated post-
operative course but died 6years later of another
spontaneous colon perforation. Pelvic pains and
instability necessitating the use of a pelvic belt or
crutches, or both, were reported in 26% of cases in
the group of affected women compared with 7% of
cases in the group of unaffected women (p,0.05).
These complications did not occur in the women
with EDS type I, and were equally distributed over
EDS types II, III, and IV. Complaints related to
varicosis were not reported. One woman with EDS
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type I had an orbital bleeding during delivery that
was treated conservatively.
Fetal and neonatal outcome
Fetal death after 24weeks of gestation occurred in
two patients with EDS type II in the early third
trimester. The cause of death could not be estab-
lished from the records, and there is no evidence
as to whether or not these fetuses were affected.
The neonatal outcome is summarized in Table
III in relation to the presence or absence of EDS
in the mother and to the condition of the neonate.
In the 91 affected neonates EDS type I was present
in 8%, type II in 26%, type III in 31%, and type
IV in 11%. In 21% the type could not be estab-
lished with certainty, and in the remaining 3% an-
other type was present (VI, VII or VIII).
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Table III. Neonatal outcome in the mothers with and without the Ehlers–Danlos syndrome. Values are numbers
Mothers Infants
Affected Unaffected Affected Unaffected Unknown
(nΩ46) (nΩ33) (nΩ91) (nΩ55) (nΩ24)
Live births 127 43 91 55 24
Infants with EDS 48 43 91 – –
Neonatal death 0 0 0 0 0
Preterm 28 17 29 8 8
Small-for-gestational age* 10 0 6 4 0
Abnormal presentation 15 1 10 5 1
PROM 25 21 31 105
Congenital defects
Clubfoot 1 2 3 0 0
Spina bifida 1 0 1 0 0
Diaphragmatic hernia 0 1 1 0 0
Cardiac VSD 0 1 1 0 0
Other abnormalities
Shoulder luxation 2 0 2 0 0
Fractured cheekbone 1 0 1 0 0
Floppy infant syndrome 7 5 12 0 0
*Birthweight below 10th percentile of reference curve of weight for gestational age, corrected for parity and sex.
EDS, Ehlers-Danlos syndrome; PROM, preterm rupture of membranes; VSD, ventricular septal defect.
Apgar scores were available in 80% of the new-
borns and were comparable between groups. The
proportion of small-for-gestational age infants was
not different between the affected and the non-
affected newborns. Small-for-gestational age was
only found in the newborns of affected mothers.
The proportion of abnormal presentations was
similar in the affected and the nonaffected infants,
but numbers are small. In 17% of the infants with
EDS type III an abnormal presentation occurred.
In 13% of the affected newborns, but in none of
the healthy infants, the floppy infant syndrome
was recognized.
A few congenital or acquired defects were ob-
served, without apparent differences between
groups. All cases concerned affected the newborns
and all survived.
Discussion
A large retrospective study of EDS patients and
their pregnancies is presented here based on data
obtained from the Dutch Ehlers–Danlos Associ-
ation. Such a study is likely to suffer from selection
bias because the occurrence of a complicated preg-
nancy may well have induced the patient and her
family to join the Association. However, there are
no clues to suspect that more severe or milder cases
of EDS are members of the Dutch Ehlers–Danlos
Association. For instance, EDS type IV was found
in 11% of cases, which is as much as would be
present in EDS patients in a general population,
and it is in this group that severe morbidity is ex-
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pected. Based on an estimated prevalence of 1:
5000 there will be approximately 3000 individuals
with EDS in the Netherlands, with a population of
approximately 15 million. Approximately 200000
deliveries occur per year and, if the birth rate
among EDS patients is similar to that in the gen-
eral population, each year approximately 40 EDS
mothers may be expected to give birth, and 40
EDS babies may be born. Selection bias is sug-
gested by the fact that only about 30% of approxi-
mately 800 pregnancies estimated to have occurred
in the past 20years are included in this study. On
the other hand, the birth rate in women with EDS
may be lower than that in the general population.
In 1997, a new classification of EDS in six major
types was proposed (4), but in this study the classi-
fication in nine types was applied (3) because all
patients recruited were diagnosed before 1997, and
comparison with literature data was possible. The
course and outcome of pregnancy in the women
with EDS were compared with those in healthy
women who delivered one or more neonates
affected with EDS, and who were also members of
the Dutch Ehlers–Danlos Association. These
women were chosen as the control group because
their pregnancies took place during the same 20
years’ period as those in the affected women. Be-
cause the women were aware of EDS, the recall
bias in the control group may be expected to be
comparable to that in the study group. On the
other hand, the fact that a significantly higher pro-
portion of pregnancies in the affected women
(66%) than in the controls (46%) was found to be
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evaluable may also have introduced bias. Because
the extent of preconceptional counseling could not
be reliably assessed, the possibility of bias resulting
from counseling cannot be excluded.
Considering the low prevalence of the syndrome
a controlled prospective study of the interaction
between EDS and pregnancy is not quite feasible
and would also be biased because at present EDS
patients should receive preconceptional counsel-
ing. Some counseled women would refrain from
pregnancy, and only counseled women would be-
come pregnant and enter the study, which may be
expected to influence the frequency and nature of
complications.
Serious complications and maternal mortality
are reported in the literature associated with preg-
nancy and delivery in women with EDS type IV,
such as bowel ruptures, ruptures of major arteries,
and ruptures of the uterus and birth canal (2, 5, 6,
10). Recently, Pepin et al. reviewed the clinical and
family histories, and medical and surgical compli-
cations in 220 index patients with biochemically
confirmed EDS type IV and 199 of their affected
relatives (2). Eighty-one of the women had had a
total of 183 pregnancies, and 12 of the women died
during the peripartum period of uterine rupture
(5) and vessel rupture (7). Most authors recom-
mend a cesarean section for patients with type lV
(6, 11, 12) and the finding of Pepin et al. (2) that
almost half the number of cases of maternal mor-
tality were as a result of uterine rupture during lab-
or seems to support that recommendation. In our
study, which included 11 patients with type lV, one
bowel rupture following vaginal delivery was re-
ported and no cesarean sections were performed.
Although vascular ruptures are considered the
characteristic complication of EDS type IV the sig-
moid is a frequent site of rupture. The patient sur-
vived and there is no evidence that performing a
cesarean section could have prevented the bowel
rupture. In our study the incidence of compli-
cations in the women with EDS type lV was not
different from that in the patients with other types
of EDS, but the numbers are small. Another expla-
nation for the relatively low morbidity in the EDS
type lV patients in this study may be the fact that
the EDS type lV families have been identified with
longer longevity and less pregnancy-associated
morbidity (13). The distribution and prevalence of
the responsible point mutation, or other, in the
COL3A1 gene in these EDS type lV families in the
world is unknown.
The incidence of pelvic pain, instability, and in
some patients a diagnosis of symphysiolysis was
high (26%) in all the pregnant women with EDS,
except in those with type l. The incidence is mark-
edly higher than that found in the control group
C Acta Obstet Gynecol Scand 81 (2002)
(7%) and in a general obstetric population (1%)
(14). A pelvic belt or crutches may be used prophy-
lactically to alleviate the complaints. In some of
the patients severe pains and even chronic dis-
ability persisted after delivery. There is no evidence
that abdominal delivery prevents deterioration of
signs and symptoms of pelvic instability (7, 14).
Decisions concerning whether or not a cesarean
section should be performed must be individual-
ized, and depend on physical condition, possibil-
ities of adequate analgesia, and course and out-
come of previous pregnancies. Usually a sensible
decision concerning the mode of delivery can be
made in agreement with the patient’s wishes after
she has been fully counseled.
Previous reports indicate a risk of 20–25% of
preterm delivery in women with EDS (12, 15). This
is in agreement with the results of this study, with
a preterm delivery rate of 22%. However, the inci-
dence of preterm delivery in the control group
(40%) was significantly higher. The observation
that the risk of preterm delivery was 12.5% in the
affected women with a healthy fetus, but 40% in
the control group of healthy mothers with an
affected fetus, and was usually caused by spon-
taneous rupture of membranes, suggests that the
fetal connective tissue disorder may affect the fetal
membranes, rather than the maternal disorder the
uterine tissues. It has been shown that the mem-
branes of fetuses with connective tissue disorders
have an abnormal collagen content and structure
(16) and are weaker than normal membranes,
which may be an explanation for the elevated pre-
term delivery rate. The results of this study do not
suggest a role of the cervix as a causal factor of
preterm delivery, as no clear cases of cervical in-
competence were found. Preterm labor, preterm
rupture of membranes, and preterm delivery are
associated in approximately 80% of cases (16) with
chorioamniotic membrane infections. Therefore,
repeated cervical, vaginal, and urinary cultures
should be part of antenatal care in women with
EDS or pregnant women with an affected spouse.
No data are available on the possible benefits of
longitudinal cervical length measurements or
fibronectin determinations in vaginal or cervical
fluids in these patients.
In this study, all four twin pregnancies resulted
in spontaneous, extremely preterm deliveries. In
the literature no data are available on the course
and outcome of twin pregnancies in women with
EDS. At present, EDS patients may request egg
cell donation, embryo transfer procedures, or do-
nor sperm if the partner is affected, in order to
prevent an affected infant. Ovulation induction, in-
vitro fertilization, and embryo transfer are associ-
ated with an increased frequency of multiple preg-
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nancies (17), and prudence seems to be indicated
with the use of these techniques when EDS is in-
volved in order to avoid multiple pregnancies.
We found a higher incidence of abnormal fetal
presentations, in particular breech, in the women
with EDS (12%) compared with the control group
(2%). The highest incidence was found in the
women with EDS type III (19%). However, the
numbers are small and the differences were not
statistically significant. In the literature only one
article was found with the suggestion of an in-
creased risk of abnormal fetal presentation at birth
in women with EDS (18).
Postpartum bleeding occurred significantly more
frequently when the mother had EDS than in the
nonaffected women; a particular high incidence
was noted in the patients with EDS type l (33%).
The elevated frequency of increased blood loss
postpartum may be attributed to specific patho-
logic conditions of EDS, such as atonia of the
uterus resulting from ineffective contractions, ab-
normal hemostasis (19), and lesions of the birth
canal. It has been suggested that the use of
DDAVP (l-desamino-8-D-argine vasopressine) in
cases of EDS-induced abnormal hemostasis could
be useful (19).
The frequency of third degree perineal tears and
complicated vaginal and perineal lacerations was
8% in the affected women in our study, which is
in general agreement with the literature, and these
lesions were not observed in the control group. It
may be difficult to prevent these complications. Al-
though there is evidence that a prophylactic medi-
olateral episiotomy may prevent third-degree peri-
neal tears in a general obstetric population (20),
EDS patients may have slow and complicated heal-
ing of the episiotomy wound. Also, because of the
laxity of the perineal tissue, an episiotomy may
even be indicated less often than in nonaffected
women. It may therefore be concluded that an epi-
siotomy should be performed in patients with EDS
for the same reasons as in women without EDS.
The Ehlers–Danlos syndrome is an inheritable
connective tissue disorder, and an influence of the
presence or absence of the syndrome in fetuses and
newborns on the outcome may be expected. The
diagnosis of EDS in newborns is often difficult,
and long-term pediatric follow up is indicated. In
our study, infants with a late diagnosis were also
included. Of the infants of affected mothers 38%
were affected, somewhat less than the expected
percentage of about 50. However, the numbers are
small and a considerable percentage of diagnoses
are labeled unknown.
A few congenital defects were found, of which
the hernial defects of clubfoot and joint luxations
have previously been reported to occur in conjunc-
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tion with EDS (1, 21). The floppy infant syndrome
is another, potentially severe manifestation ob-
served in 13% of the newborns with EDS, and in
none of the nonaffected infants. The syndrome is
most likely to be the result of the connective tissue-
related weakness of muscle contraction and ten-
dons (22). Recognition of this condition is import-
ant because of its extensive differential diagnosis
with, among others, neonatal respiratory distress
and neuromuscular disease.
Conclusion
In conclusion, obstetricians should be aware of the
clinical signs and symptoms that may indicate
EDS in a pregnant patient, of the diagnostic pos-
sibilities, and of the potential risks. Knowledge of
the diagnosis, in particular in patients with type
IV, has important consequences for reproductive
counseling and management of pregnancy and
complications. Preconceptional diagnosis and
evaluation of risk factors are corner stones of
management in women with EDS. In EDS type I,
II, and III pregnancy is generally well-tolerated,
with favorable maternal and neonatal outcome,
but maternal complications related to connective
tissue dysfunction such as pelvic instability, and
obstetric problems such as preterm delivery, post-
partum hemorrhage and complicated perineal
lacerations occur more often than in the general
population. Ehlers–Danlos syndrome type IV may
be associated with severe maternal complications.
All pregnancies in women with EDS carry a 50%
risk of resulting in an affected infant. The results
of this study underline the need for long-term
pediatric follow up of infants of mothers or fathers
with EDS, and for the provision of appropriate
specialized care when required.
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